Results 101 to 110 of about 273,177 (229)

Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide.

open access: yes, 2017
BackgroundBesides inclusion in 1st line regimens against tuberculosis (TB), pyrazinamide (PZA) is used in 2nd line anti-TB regimens, including in the short regimen for multidrug-resistant TB (MDR-TB) patients.
“Union short MDR-TB regimen study group”   +39 more
core   +1 more source

Clinical Profiles of Multidrug-Resistant and Rifampicin-Monoresistant Tuberculosis in Korea, 2018–2021: A Nationwide Cross-Sectional Study [PDF]

open access: yesTuberculosis and Respiratory Diseases
Background This study aimed to identify the clinical characteristics of multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) in the Republic of Korea. Methods Data of notified people with tuberculosis between July 2018 and December 2021 were
Jinsoo Min   +11 more
doaj   +1 more source

Drug susceptibility testing and MDR-TB cases diagnosed by TB diagnostic algorithm.

open access: yes, 2017
Data is not shown for cases with TB category “unknown” (435 cases (8.9%) in smear/culture group and 464 (8.6%) in Xpert group) but can be calculated based on the numbers shown. DST (drug susceptibility tests) and MDR-TB (multidrug- resistant tuberculosis)
Judy Caldwell (342298)   +4 more
core   +1 more source

Multidrug-Resistant Tuberculosis in Rural Eastern Cape, South Africa: Clinical, Bacteriological, and Programmatic Predictors of Poor Treatment Outcomes

open access: yesMicroorganisms
Drug-resistant tuberculosis (DR-TB), particularly multidrug-resistant TB (MDR-TB), remains a significant public health challenge in rural South Africa, where diagnostic and treatment infrastructure is limited.
Mbulelo Cebisa   +4 more
doaj   +1 more source

Yield of facility-based verbal screening amongst household contacts of patients with multi-drug resistant tuberculosis in Pakistan

open access: yesJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2017
Background: Household contacts of multidrug-resistant tuberculosis (MDR-TB) patients are at a high risk of getting infected with TB/MDR-TB, therefore symptomatic or vulnerable individuals should be screened and treated early.
Ejaz Qadeer   +7 more
doaj   +1 more source

Characteristics of MDR-TB cohort.

open access: yes, 2018
Characteristics of MDR-TB cohort.
Malik M. Parmar (5088815)   +6 more
core   +1 more source

Beyond the CE Mark: A Call to Action for Minimum CGM Accuracy Standards in Central and Eastern European Nations

open access: yes
Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 9747-9752, November 2026.
Tomasz Klupa   +14 more
wiley   +1 more source

Previous TB treatment history of MDR-TB patients in Lesotho.

open access: yes, 2013
Previous TB treatment history of MDR-TB patients in Lesotho.
Paul E. Farmer (168673)   +5 more
core   +1 more source

Multidrug-resistant tuberculosis and risk factors associated with its development: a retrospective study

open access: yesJournal of Infection in Developing Countries, 2015
Introduction: Multidrug-resistant tuberculosis (MDR-TB) has emerged as a major clinical public health threat and challenges the national TB control program in Malaysia. Data that elaborates on the risk factors associated with the development of MDR-TB is
Omar Sald Elmi   +5 more
doaj   +1 more source

Treatment outcomes of patients with Multidrug-Resistant Tuberculosis (MDR- TB) compared with Non-MDR-TB infections in peninsular malaysia

open access: yes, 2016
Background: Treating patients with multidrug-resistant tuberculosis (MDR-TB) strains is more complicated, complex, toxic, expensive, than treating patients with susceptible TB strains.
Azhanie Sardangi
core  

Home - About - Disclaimer - Privacy